Abstract:The therapeutic potential of benzimidazole has brought them widespread recognition as a class of heterocyclic compounds having nitrogen-containing rings. In recent years, there has been a lot of focus on synthesizing these molecules in order to reveal a broad range of biological actions. Therefore, a novel series of 1H-benzo[ d ]imidazole-5-carboxamide derivatives were designed, synthesized, and investigated for their antioxidant and enzyme inhibitory activities. The structural elucidation of synthesized compounds was accomplished by a variety of spectroscopic techniques, such as elemental analysis, 1 H and 13 C NMR, and LC-MS. Using the DPPH and FRAP techniques, the antioxidant activity of newly synthesized compounds was assessed. With IC 50 values of 81.45, 72.14, and 77.35 μM, respectively, in the DPPH assay and 86.07, 75.02, and 81.14 μM, respectively, in the FRAP assay, the compounds 10c, 10f, and 10 g shown have significant antioxidant activity in comparisons with reference drugs ascorbic acid and Trolox. Furthermore, the inhibitory activity of xanthine oxidase (XO) and lipoxygenase (LOX) enzymes was assessed for the most potent molecules. Compounds 10c, 10f, and 10 g show superior inhibitory effects than reference drugs allopurinol and baicalein, with IC 50 values of 19.52, 13.95, and 15.83 μM, respectively, against LOX and 26.14, 18.43, and 22.05 μM, respectively, against the XO enzyme. Moreover, studies using molecular docking were conducted to gain a deeper understanding of the interactions between the 3NM8 and 1N8Q protein and the most effective compounds, 10c, 10f, and 10 g. While compared to the reference medications, the studied compounds showed substantial docking scores and binding affinities, as indicated by docking studies. Through the use of drug-likeness and structure-activity relationships (SAR), an association between the newly synthesized compounds' biological and physicochemical properties was established.

Synthesis, Crystal Structure And Anti-Fatigue Effects Of Some Benzamide Derivatives

Synthesis and Antifatigue Activities of New Benzamide Derivatives

Anti-fatigue activity screening of novel positive allosteric modulators on AMPA receptor

1-(1,3-Benzodioxol-5-Yl-Carbo-Nyl) Piperidine, A Modulator Of Alpha-Amino-3-Hydroxy-5-Methyl-4-Isoxazole Propionic Acid Receptor, Ameliorates Exercise-Induced Fatigue In Mice

Screen of AMPA Receptor Modulators on Anti-fatigue and Wakefulness-promoting Effect

Synthesis, Structure-Activity Relationships, and Biological Evaluation of A Series of Benzamides As Potential Multireceptor Antipsychotics

Synthesis, molecular docking, enzyme inhibition and antioxidant potential of new 1H-benzo[ d ]imidazole-5-carboxamide derivatives

Synthesis and Biological Evaluation of Novel Difluorophenyl Methanesulfinyl Acetamide Derivatives

Studies on the synthesis and anti-fatigue activity of the salidroside derivatives

( S )- N -Benzyl-1-phenyl-3,4-dihydroisoqunoline-2(1 H )-carboxamide Derivatives, Multi-Target Inhibitors of Monoamine Oxidase and Cholinesterase: Design, Synthesis, and Biological Activity.

Synthesis, biological evaluation and 3D-QSAR study of 1-(1,4-benzodioxan-2-ylcaronyl)-4-aryloxyalkyl-piperazines as α1-adrenoceptor antagonists

Synthesis, Characterization and Biological Evaluation of Benzothiazole-Isoquinoline Derivative

Design, Synthesis and Evaluation of 3-(2-aminoheterocycle)-4-benzyloxyphenylbenzamide Derivatives As BACE-1 Inhibitors

Continuation of Structure-Activity Relationship Study of Novel Benzamide Derivatives As Potential Antipsychotics.

Synthesis of 1-(1,3-Benzodioxol-5-ylcarbonyl)piperidine by a New Method and Its Crystal Structure

Coplanar Effect Studies on the Benzamides of Dopamine D2 Receptor Imaging Agents

Design, Synthesis, In Vitro And In Vivo Evaluation Of Benzylpiperidine-Linked 1,3-Dimethylbenzimidazolinones As Cholinesterase Inhibitors Against Alzheimer'S Disease

Design, Synthesis and Preliminary Bioactivity Evaluation of Bitopic Benzopyranomorpholine Analogues As Selective Dopamine D3 Receptor Ligands As Anti-Drug Addiction Therapeutic Agents

Further structure-activity relationships study of hybrid 7-{[2-(4-phenylpiperazin-1-yl)ethyl]propylamino}-5,6,7,8-tetrahydronaphthalen-2-ol analogues: identification of a high-affinity D3-preferring agonist with potent in vivo activity with long duration of action.

Synthesis and Preliminary Antihypoxic Activities of Novel Substituted Benzylamine N-glycosides

Synthesis and Biological Activity of 1-(1,4-benzodioxan-2-yl-carbonyl)-4-aryloxy-alkyl-piperazine As Α_1-Adrenoceptor Antagonists